Your browser doesn't support javascript.
loading
SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant.
Guo, Hongchao; Yu, Xuan; Liu, Yu; Paik, David T; Justesen, Johanne Marie; Chandy, Mark; Jahng, James W S; Zhang, Tiejun; Wu, Weijun; Rwere, Freeborn; Zhao, Shane Rui; Pokhrel, Suman; Shivnaraine, Rabindra V; Mukherjee, Souhrid; Simon, Daniel J; Manhas, Amit; Zhang, Angela; Chen, Che-Hong; Rivas, Manuel A; Gross, Eric R; Mochly-Rosen, Daria; Wu, Joseph C.
Afiliação
  • Guo H; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Yu X; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Liu Y; Department of Medicine (Division of Cardiology), Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Paik DT; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Justesen JM; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Chandy M; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Jahng JWS; Department of Medicine (Division of Cardiology), Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Zhang T; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Wu W; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Rwere F; Department of Medicine (Division of Cardiology), Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Zhao SR; Biomedical Data Science, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Pokhrel S; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Shivnaraine RV; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Mukherjee S; Department of Medicine (Division of Cardiology), Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Simon DJ; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Manhas A; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Zhang A; Department of Medicine (Division of Cardiology), Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Chen CH; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Rivas MA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Gross ER; Department of Medicine (Division of Cardiology), Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Mochly-Rosen D; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Wu JC; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Sci Transl Med ; 15(680): eabp9952, 2023 01 25.
Article em En | MEDLINE | ID: mdl-36696485
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Células-Tronco Pluripotentes Induzidas / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Células-Tronco Pluripotentes Induzidas / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos